Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Clinical Intelligence
Clinical Intelligence
RSS
S*BIO to initiate phase III myelofibrosis trial
October 25, 2011
CenterWatch Staff
Oncothyreon advances to phase II of PX-866 trial
October 20, 2011
CenterWatch Staff
Genticel completes patient recruitment for ProCervix trial
October 19, 2011
CenterWatch Staff
Roche’s Herceptin phase III trial shows positive results
October 18, 2011
CenterWatch Staff
VIVUS resubmits NDA for Qnexa
October 17, 2011
CenterWatch Staff
ChemoCentryx initiates phase II CCX168 trial
October 17, 2011
CenterWatch Staff
Echo Therapeutics launches diabetes study
October 13, 2011
CenterWatch Staff
Biotron’s phase IIa Hepatitis C study shows positive results
October 11, 2011
CenterWatch Staff
FDA approves Combivent Respimat for COPD
October 11, 2011
CenterWatch Staff
FDA approves Fluoxetine 60mg tablets
October 11, 2011
CenterWatch Staff
Previous
1
2
…
124
125
126
127
128
129
130
131
132
…
166
167
Next
Upcoming Events
26
Jun
Streamlining Clinical Trial Agreement Negotiations: Avoiding Common Pitfalls for Faster Signatures
27
Jun
Gene Editing at the Cutting Edge of Molecular Medicine: Clinical, Ethical, and Biosafety Concerns in CRISPR Clinical Trials
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here